Electrophysiological and Histopathological Characteristics of Ventricular Tachycardia Associated With Primary Cardiac Tumors.

electrophysiological study myocardial disarray re-entry surgery tumor ventricular tachycardia

Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
28 Sep 2023
Historique:
received: 24 04 2023
revised: 11 08 2023
accepted: 30 08 2023
medline: 19 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: aheadofprint

Résumé

Ventricular tachycardia (VT) associated with primary cardiac tumors (PCTs) originating from the ventricles is rare, but lethal, in young patients. This study aimed to clarify the mechanisms underlying primary cardiac tumor-related ventricular tachycardia (PCT-VT) and establish a therapeutic strategy for this form of VT. Among 67 patients who underwent surgery for VT at our institute between 1981 and 2020, 4 patients aged 1 to 34 years, including 3 males, showed PCT-VT (fibroma, 2; lipoma, 1; and hamartoma, 1), which was investigated using a combination of intraoperative electroanatomical mapping and histopathological studies. All 4 patients developed electrical storms of sustained VTs refractory to multiple drugs and repetitive endocardial ablations. The VT mechanism was re-entry, and intraoperative electroanatomical mapping showed a centrifugal activation pattern originating from the border between the tumor and healthy myocardium, where fractionated potentials were detected during sinus rhythm. Histopathological studies of serial sections of specimens acquired from these areas revealed tumor infiltration into the surrounding myocardium with cell disorganization, exhibiting myocardial disarray. Several myocardia entrapped in the tumor edges contributed to the development and sustainment of re-entrant VT activation. In the 2 patients in whom complete resection was unfeasible, encircling cryoablation to entirely isolate the unresectable tumor was effective in suppressing VT occurrence. The mechanism underlying PCT-VT involves re-entry localized at the tumor edges. Myocardial disarray associated with tumor infiltration is a substrate for this form of VT. Cryoablation along the border between the tumor and myocardium is a promising therapeutic option for unresectable PCT-VT.

Sections du résumé

BACKGROUND BACKGROUND
Ventricular tachycardia (VT) associated with primary cardiac tumors (PCTs) originating from the ventricles is rare, but lethal, in young patients.
OBJECTIVES OBJECTIVE
This study aimed to clarify the mechanisms underlying primary cardiac tumor-related ventricular tachycardia (PCT-VT) and establish a therapeutic strategy for this form of VT.
METHODS METHODS
Among 67 patients who underwent surgery for VT at our institute between 1981 and 2020, 4 patients aged 1 to 34 years, including 3 males, showed PCT-VT (fibroma, 2; lipoma, 1; and hamartoma, 1), which was investigated using a combination of intraoperative electroanatomical mapping and histopathological studies.
RESULTS RESULTS
All 4 patients developed electrical storms of sustained VTs refractory to multiple drugs and repetitive endocardial ablations. The VT mechanism was re-entry, and intraoperative electroanatomical mapping showed a centrifugal activation pattern originating from the border between the tumor and healthy myocardium, where fractionated potentials were detected during sinus rhythm. Histopathological studies of serial sections of specimens acquired from these areas revealed tumor infiltration into the surrounding myocardium with cell disorganization, exhibiting myocardial disarray. Several myocardia entrapped in the tumor edges contributed to the development and sustainment of re-entrant VT activation. In the 2 patients in whom complete resection was unfeasible, encircling cryoablation to entirely isolate the unresectable tumor was effective in suppressing VT occurrence.
CONCLUSIONS CONCLUSIONS
The mechanism underlying PCT-VT involves re-entry localized at the tumor edges. Myocardial disarray associated with tumor infiltration is a substrate for this form of VT. Cryoablation along the border between the tumor and myocardium is a promising therapeutic option for unresectable PCT-VT.

Identifiants

pubmed: 37855769
pii: S2405-500X(23)00686-2
doi: 10.1016/j.jacep.2023.08.033
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Hiroshige Murata (H)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: https://twitter.com/Muratahiroshige.

Yasushi Miyauchi (Y)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Takashi Nitta (T)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Shun-Ichiro Sakamoto (SI)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Shinobu Kunugi (S)

Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Yosuke Ishii (Y)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Akira Shimizu (A)

Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Yuhi Fujimoto (Y)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Hiroshi Hayashi (H)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Teppei Yamamoto (T)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Kenji Yodogawa (K)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Mitsunori Maruyama (M)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Shinji Kaneko (S)

Department of Cardiology, Toyota Kosei Hospital, Aichi, Japan.

Hidemori Hayashi (H)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Kyoko Soejima (K)

Department of Cardiology, Kyorin University, Tokyo, Japan.

Akihiko Nogami (A)

Department of Cardiology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.

Kuniya Asai (K)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Yu-Ki Iwasaki (YK)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: iwasaki@nms.ac.jp.

Classifications MeSH